Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.

NCT04593420 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT04593420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04593420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
November 30, 2020
Completion date
December 8, 2022
Enrollment
817 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer